Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
How to buy Quest Diagnostics Incorporated stock
Learn how to easily invest in Quest Diagnostics Incorporated stock.
Quest Diagnostics Incorporated is a diagnostics & research business based in the US. Quest Diagnostics Incorporated shares (DGX) are listed on the NYSE and all prices are listed in US Dollars. Quest Diagnostics Incorporated employs 50,000 staff and has a trailing 12-month revenue of around $10.3 billion.
How to buy Quest Diagnostics Incorporated stock
- Open a stock trading account. Use our comparison table or choose from our Top Picks.
- Confirm your payment details. Fund your account with a bank transfer, debit card or credit card and take advantage of any signup bonuses.
- Search for the stock by name or ticker symbol – DGX. It's that simple.
- Trade stocks for $0 and no annual fee
- Start trading with a $0 minimum deposit
- Get up to $1,000 when you fund a new account within 30 days
- Commission-free trading
- Commission-free crypto
- No minimum account balance
- $0 commissions on stocks and ETFs
- $0 closing commissions on stock and ETF options
- Get $200 in US stocks when you open and fund an account with min. $2,000 for 3+ mos.
What's in this guide?
- DGX shares summary
- Compare share dealing platforms
- Is DGX stock a buy or sell?
- Stock performance over time
- Is DGX suitable for ethical investing?
- Are DGX shares over-valued?
- Quest Diagnostics Incorporated's financials
- How volatile are DGX shares?
- Does Quest Diagnostics Incorporated pay a dividend?
- Have DGX shares ever split?
- Other common questions
Quest Diagnostics Incorporated stock price (NYSE: DGX)Use our graph to track the performance of DGX stocks over time.
Quest Diagnostics Incorporated shares at a glance
|Latest market close||$144.91|
|52-week range||$119.22 - $157.63|
|50-day moving average||$150.57|
|200-day moving average||$138.15|
|Wall St. target price||$150.53|
|Dividend yield||$2.6 (1.8%)|
|Earnings per share (TTM)||$10.19|
Buy Quest Diagnostics Incorporated stocks from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
Information on this page is for educational purposes only. Finder is not an advisor or brokerage service, and we don't recommend investors to trade specific stocks or other investments.
Finder is not a client of any featured partner. We may be paid a fee for referring prospective clients to a partner, though it is not a recommendation to invest in any one partner.
Is it a good time to buy Quest Diagnostics Incorporated stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Quest Diagnostics Incorporated price performance over time
|1 week (2023-01-18)||-0.13%|
|1 month (2022-12-23)||N/A|
|3 months (2022-10-25)||0.60%|
|6 months (2022-07-27)||7.90%|
|1 year (2022-01-27)||7.28%|
|2 years (2021-01-27)||15.82%|
|3 years (2020-01-27)||32.37%|
|5 years (2018-01-26)||35.91%|
Is Quest Diagnostics Incorporated stock undervalued or overvalued?
Valuing Quest Diagnostics Incorporated stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Quest Diagnostics Incorporated's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Quest Diagnostics Incorporated's P/E ratio
Quest Diagnostics Incorporated's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 14x. In other words, Quest Diagnostics Incorporated shares trade at around 14x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
Quest Diagnostics Incorporated's PEG ratio
Quest Diagnostics Incorporated's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.2373. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Quest Diagnostics Incorporated's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Quest Diagnostics Incorporated's EBITDA
Quest Diagnostics Incorporated's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $2.3 billion.
The EBITDA is a measure of a Quest Diagnostics Incorporated's overall financial performance and is widely used to measure a its profitability.
Quest Diagnostics Incorporated financials
|Revenue TTM||$10.3 billion|
|Operating margin TTM||18.23%|
|Gross profit TTM||$4.2 billion|
|Return on assets TTM||8.76%|
|Return on equity TTM||20.4%|
|Market capitalisation||$16.4 billion|
TTM: trailing 12 months
Quest Diagnostics Incorporated's environmental, social and governance track record
Environmental, social and governance (known as ESG) criteria are a set of three factors used to measure the sustainability and social impact of companies like Quest Diagnostics Incorporated.
When it comes to ESG scores, lower is better, and lower scores are generally associated with lower risk for would-be investors.
Quest Diagnostics Incorporated's total ESG risk score
Total ESG risk: 18.33
Socially conscious investors use ESG scores to screen how an investment aligns with their worldview, and Quest Diagnostics Incorporated's overall score of 18.33 (as at 12/31/2018) is excellent – landing it in it in the 16th percentile of companies rated in the same sector.
ESG scores are increasingly used to estimate the level of risk a company like Quest Diagnostics Incorporated is exposed to within the areas of "environmental" (carbon footprint, resource use etc.), "social" (health and safety, human rights etc.), and "governance" (anti-corruption, tax transparency etc.).
Quest Diagnostics Incorporated's environmental score
Environmental score: 0.86/100
Quest Diagnostics Incorporated's environmental score of 0.86 puts it squarely in the 1st percentile of companies rated in the same sector. This could suggest that Quest Diagnostics Incorporated is a leader in its sector terms of its environmental impact, and exposed to a lower level of risk.
Quest Diagnostics Incorporated's social score
Social score: 10.42/100
Quest Diagnostics Incorporated's social score of 10.42 puts it squarely in the 1st percentile of companies rated in the same sector. This could suggest that Quest Diagnostics Incorporated is a leader in its sector when it comes to taking good care of its workforce and the communities it impacts.
Quest Diagnostics Incorporated's governance score
Governance score: 5.77/100
Quest Diagnostics Incorporated's governance score puts it squarely in the 1st percentile of companies rated in the same sector. That could suggest that Quest Diagnostics Incorporated is a leader in its sector when it comes to responsible management and strategy, and exposed to a lower level of risk.
Quest Diagnostics Incorporated's controversy score
Controversy score: 3/5
ESG scores also evaluate any incidences of controversy that a company has been involved in. Quest Diagnostics Incorporated scored a 3 out of 5 for controversy – a middle-of-the-table result reflecting that Quest Diagnostics Incorporated hasn't always managed to keep its nose clean.
Environmental, social, and governance (ESG) summary
|Total ESG score||18.33|
|Total ESG percentile||16.26|
|Environmental score percentile||1|
|Social score percentile||1|
|Governance score percentile||1|
|Level of controversy||3|
Quest Diagnostics Incorporated share dividends
Dividend payout ratio: 23.43% of net profits
Recently Quest Diagnostics Incorporated has paid out, on average, around 23.43% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 1.8% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Quest Diagnostics Incorporated shareholders could enjoy a 1.8% return on their shares, in the form of dividend payments. In Quest Diagnostics Incorporated's case, that would currently equate to about $2.6 per share.
While Quest Diagnostics Incorporated's payout ratio might seem low, this can signify that Quest Diagnostics Incorporated is investing more in its future growth.
Quest Diagnostics Incorporated's most recent dividend payout was on 31 January 2023. The latest dividend was paid out to all shareholders who bought their shares by 16 January 2023 (the "ex-dividend date").
Have Quest Diagnostics Incorporated's shares ever split?
Quest Diagnostics Incorporated's shares were split on a 2:1 basis on 20 June 2005. So if you had owned 1 share the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your Quest Diagnostics Incorporated shares – just the quantity. However, indirectly, the new 50% lower share price could have impacted the market appetite for Quest Diagnostics Incorporated shares which in turn could have impacted Quest Diagnostics Incorporated's share price.
Quest Diagnostics Incorporated share price volatility
Over the last 12 months, Quest Diagnostics Incorporated's shares have ranged in value from as little as $119.2181 up to $157.6292. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Quest Diagnostics Incorporated's is 0.9672. This would suggest that Quest Diagnostics Incorporated's shares are less volatile than average (for this exchange).
Quest Diagnostics Incorporated overview
Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to patients, clinicians, hospitals, independent delivery networks, health plans, employers, direct contract entities, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile paramedics, nurses, and other health and wellness professionals. The company also provides risk assessment services for the life insurance industry; and healthcare organizations and clinicians robust information technology solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey. .
Quest Diagnostics Incorporated in the news
Quest Diagnostics (DGX) to Report Q4 Earnings: What's in Store?
Advancing Healthcare Equity in Underserved Communities
More Americans Know Their Horoscope Sign Than Their Blood Type, Survey Reveals
Frequently asked questionsWhat percentage of Quest Diagnostics Incorporated is owned by insiders or institutions?
Currently 0.717% of Quest Diagnostics Incorporated shares are held by insiders and 95.182% by institutions. How many people work for Quest Diagnostics Incorporated?
Latest data suggests 50,000 work at Quest Diagnostics Incorporated. When does the fiscal year end for Quest Diagnostics Incorporated?
Quest Diagnostics Incorporated's fiscal year ends in December. Where is Quest Diagnostics Incorporated based?
Quest Diagnostics Incorporated's address is: 500 Plaza Drive, Secaucus, NJ, United States, 07094 What is Quest Diagnostics Incorporated's ISIN number?
Quest Diagnostics Incorporated's international securities identification number is: US74834L1008 What is Quest Diagnostics Incorporated's CUSIP number?
Quest Diagnostics Incorporated's Committee on Uniform Securities Identification Procedures number is: 74834L100
More guides on Finder
How to buy TXO Energy (TXO) stock when it goes public
Everything we know about the TXO Energy IPO, plus information on how to buy in.
How to buy Brera (BREA) stock when it goes public
Everything we know about the Brera IPO, plus information on how to buy in.
How to invest in the S&P 500
What you need to know about investing in the leading indicator for the overall US stock market.
How to buy IPO stock
Buying an IPO is as simple as buying any other stock, but not every trading platform offers IPO stocks.
How to buy Novo Integrated Sciences stock
Steps to owning and managing NVOS, with 24-hour and historical pricing before you buy.
How do ETFs work?
Your simple and straightforward guide to ETFs, how they work and the different types available.
What is stock lending?
Find out how stock lending works, the extra income you could potentially earn and the risks you should be aware of. Plus, compare stock trading platforms that offer stock lending.
How to buy SONDORS (SODR) stock when it goes public
Everything we know about the SONDORS IPO, plus information on how to buy in.
How to buy Bullfrog AI Holdings (BFRG) stock when it goes public
Everything we know about the Bullfrog AI Holdings IPO, plus information on how to buy in.
How to research stocks
Learn about stock analysis and how to use it to find the right company to buy.
Ask an Expert